132 results
Page 2 of 7
6-K
EX-99.4
tm21aki7tm3th03tp
18 Aug 21
RepliCel Life Sciences Announces Closing of Debt Settlement
12:34pm
6-K
EX-99.5
i4mrv3i0a e9yt
18 Aug 21
Current report (foreign)
12:20pm
20-F/A
ftqvz4 l12
31 Mar 21
Annual report (foreign) (amended)
12:00am
6-K
EX-99.5
w26cm j2andiy0
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.4
uuxh18hn839dbur02
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.3
8tpha6hh2q6wm
3 Feb 21
RepliCel and MainPointe Pharmaceuticals Sign Strategic Investment and Collaboration Agreement
12:03pm
6-K
EX-99.2
tv0kc8
22 Dec 20
Current report (foreign)
3:05pm
6-K
EX-99.1
h42bie
30 Nov 20
Condensed Consolidated Interim Financial Statements
5:19pm
6-K
EX-99.2
9wmvx8 74y1mxtp
30 Nov 20
RepliCel Announces Filing of Amended and Restated Financial Statements and Management Discussion & Analysis
10:05am
6-K
EX-99.1
gjq4po0c
30 Nov 20
RepliCel Announces Filing of Amended and Restated Financial Statements and Management Discussion & Analysis
10:05am
6-K
EX-99.1
1u0r9
13 Nov 20
Notice of Annual General and Special Meeting of Shareholders
12:00am
6-K
EX-99.1
gsn ono96lnry5vvi
15 Oct 20
Condensed Consolidated Interim Financial Statements
5:15pm
6-K
EX-99.1
qlhyy o1b5
3 Aug 20
Consolidated Financial Statements
12:00am
6-K
EX-99.1
4awembyw tj8u
31 Jul 20
Condensed Consolidated Interim Financial Statements
9:14pm
6-K
EX-99.1
q437vtaj37hja u9
6 Nov 19
Notice of Annual General and Special Meeting of Shareholders
12:00am